PremiumStock Analysis & IdeasInternational ETFs: Some of the Best Investment Opportunities Around3y agoEPPEZU
PremiumStock Analysis & IdeasInternational ETFs: Some of the Best Investment Opportunities Around3y agoEPPEZU
PremiumCompany AnnouncementsHSBC Advances Share Buy-Back, Cancels Additional Shares on Hong Kong Exchange8h ago
PremiumCompany AnnouncementsAstraZeneca’s BalanceD-CKD Trial Targets Big Gains in Advanced Kidney Care15h agoAZN
PremiumCompany AnnouncementsAstraZeneca’s New Asthma Care Trial Signals Long-Term Upside for Respiratory Investors15h agoAZN
PremiumRatingsBuy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged18h agoNVS
Buy Rating Reiterated on Novartis as Diversified Pipeline Supports Medium-Term Growth; CHF 150 Price Target Unchanged
PremiumCompany AnnouncementsShell Continues Share Buy‑Back Programme With Dual‑Market Cancellations21h ago